
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.68 | 0.76 | 0.08 |
Shares | 99.33 | 99.33 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.26 | 19.70 |
Price to Book | 3.62 | 3.89 |
Price to Sales | 1.76 | 2.23 |
Price to Cash Flow | 12.84 | 14.91 |
Dividend Yield | 1.38 | 1.49 |
5 Years Earnings Growth | 7.85 | 10.16 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.92 | 94.29 |
Industrials | 1.08 | 3.30 |
Number of long holdings: 52
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 6.45 | 769.00 | +0.87% | |
AstraZeneca | GB0009895292 | 5.64 | 11,202.0 | +0.59% | |
Novo Nordisk B | DK0062498333 | 5.26 | 310.2 | -0.91% | |
Intuitive Surgical | US46120E6023 | 3.80 | 483.36 | +0.05% | |
Thermo Fisher Scientific | US8835561023 | 3.62 | 466.57 | +0.76% | |
UnitedHealth | US91324P1021 | 3.48 | 240.98 | +1.35% | |
DexCom | US2521311074 | 3.37 | 76.25 | -3.82% | |
Fresenius SE | DE0005785604 | 3.27 | 41.500 | +0.02% | |
Boston Scientific | US1011371077 | 3.16 | 106.79 | +1.31% | |
Becton Dickinson | US0758871091 | 2.90 | 178.90 | +1.43% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology a | 1.2B | -0.59 | 14.38 | 18.16 | ||
AXA Framlington Global Technology F | 1.2B | -0.59 | 14.38 | 18.17 | ||
GB00B5LXGG05 | 1.03B | -5.38 | 15.53 | 15.47 | ||
AXA Framlington Managed Income Funa | 266.49M | 3.98 | 5.94 | 4.12 | ||
AXA Framlington Managed Income Funr | 266.49M | 3.99 | 5.94 | 4.00 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review